DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Asakura H, Ogawa H.
Potential of heparin and nafamostat combination therapy for COVID-19.
J Thromb Haemost 2020; (e-pub ahead of print)
DOI: 10.1111/jth.14858.
We do not assume any responsibility for the contents of the web pages of other providers.